Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Brief Research Report

Published on 23 Jul 2024

Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis

in Multiple Sclerosis and Neuroimmunology

Davide De Federicis
Claudia Bassani
Rosaria Rita Chiarelli
Federico Montini
Antonino Giordano
Federica Esposito
Nilo Riva
Angelo Quattrini
Vittorio Martinelli
Massimo Filippi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436717

1,570 views

Editorial

Published on 17 Jul 2024

Editorial: CNS myeloid cell function in health and disease

in Multiple Sclerosis and Neuroimmunology

Christian W. Keller
Sarah Mundt
Benjamin M. Segal

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459138

802 views

Brief Research Report

Published on 17 Jul 2024

Long-term use of rituximab increases T cell count in MS patients

in Multiple Sclerosis and Neuroimmunology

Gunnar Sigfús Björnsson
Hildur Sigurgrímsdóttir
Sólrún Melkorka Maggadóttir
Berglind Ósk Einarsdóttir
Ólafur Árni Sveinsson
Haukur Hjaltason
Sigurveig Þóra Sigurðardóttir
Björn Rúnar Lúðvíksson
Siggeir Fannar Brynjólfsson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1412668

1,533 views

Original Research

Published on 15 Jul 2024

Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Kefu Yu
Ruiqi Jiang
Ziming Li
Xiaohui Ren
Haihui Jiang
Zhigang Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1428962

4,693 views

Original Research

Published on 15 Jul 2024

Hyper-reflective foci changes in RRMS under natalizumab therapy

in Multiple Sclerosis and Neuroimmunology

Marco Puthenparampil
Elisa Basili
Marta Ponzano
Valentina Annamaria Mauceri
Alessandro Miscioscia
Elisabetta Pilotto
Paola Perini
Francesca Rinaldi
Francesca Bovis
Paolo Gallo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1421755

1,075 views

Original Research

Published on 10 Jul 2024

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis

in Multiple Sclerosis and Neuroimmunology

Vicente Peris Sempere
Guo Luo
Sergio Muñiz-Castrillo
Anne-Laurie Pinto
Géraldine Picard
Véronique Rogemond
Maarten J. Titulaer
Carsten Finke
Frank Leypoldt
Gregor Kuhlenbäumer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423149

3,449 views

Mini Review

Published on 09 Jul 2024

Unlocking the Potential: immune functions of oligodendrocyte precursor cells

in Multiple Sclerosis and Neuroimmunology

Amr Haroon
Harsha Seerapu
Li-Pao Fang
Jakob Heinrich Weß
Xianshu Bai

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425706

2,040 views
1 citation

Mini Review

Published on 05 Jul 2024

Microglia targeting by adeno-associated viral vectors

in Multiple Sclerosis and Neuroimmunology

Maria Stamataki
Björn Rissiek
Tim Magnus
Jakob Körbelin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425892

3,366 views

Original Research

Published on 03 Jul 2024

Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis

in Multiple Sclerosis and Neuroimmunology

Danyang Li
Minghua Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1390149

3,193 views
2 citations

Case Report

Published on 03 Jul 2024

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

in Multiple Sclerosis and Neuroimmunology

Neus Rabaneda-Lombarte
Aina Teniente-Serra
Anna Massuet-Vilamajó
Cristina Ramo-Tello
Silvia Presas-Rodríguez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395749

1,112 views
1 citation

Original Research

Published on 02 Jul 2024

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

in Multiple Sclerosis and Neuroimmunology

Sara Samadzadeh
Rafl Adnan
Paulina Berglova
Mahdi Barzegar
Birgit Debrabant
Stine Gundtoft Roikjaer
Michael Levy
Axel Petzold
Jacqueline Palace
Eoin P. Flanagan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380025

4,751 views
1 citation

Original Research

Published on 01 Jul 2024

The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study

in Multiple Sclerosis and Neuroimmunology

Xue Ma
Yao Wang
Xin Chen
Jun Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418309

1,834 views
2 citations

Brief Research Report

Published on 27 Jun 2024

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Alexandru Tatomir
Freidrich Anselmo
Dallas Boodhoo
Hegang Chen
Armugam P. Mekala
Vinh Nguyen
Jacob Cuevas
Violeta Rus
Horea Rus

Frontiers in Immunology

doi 10.3389/fimmu.2024.1338585

1,666 views

Editorial

Published on 19 Jun 2024

Editorial: The immune microenvironment landscape in cerebrovascular diseases

in Multiple Sclerosis and Neuroimmunology

Zhiqiang Dong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446311

737 views

Editorial

Published on 18 Jun 2024

Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease

in Multiple Sclerosis and Neuroimmunology

Shashank K. Maurya
Janina E. Borgonovo
Suryanarayan Biswal
Verónica Martínez-Cerdeño
Rajnikant Mishra
Estela M. Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1442322

1,504 views

Original Research

Published on 17 Jun 2024

Clinical features in antiglycine receptor antibody-related disease: a case report and update literature review

in Multiple Sclerosis and Neuroimmunology

Xiaoke Wu
Haifeng Zhang
Mengmeng Shi
Shaokuan Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387591

2,859 views
1 citation

Navigation group

Articles

Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis

Editorial: CNS myeloid cell function in health and disease

Long-term use of rituximab increases T cell count in MS patients

Integrated analyses of single-cell transcriptome and Mendelian randomization reveal the protective role of FCRL3 in multiple sclerosis

Hyper-reflective foci changes in RRMS under natalizumab therapy

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis

Unlocking the Potential: immune functions of oligodendrocyte precursor cells

Microglia targeting by adeno-associated viral vectors

Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

The levels of circulating cytokines and risk of neuromyelitis optica spectrum disorder: a Mendelian randomization study

Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis

Editorial: The immune microenvironment landscape in cerebrovascular diseases

Editorial: Trends in neuroimmunology: cross-talk between brain-resident and peripheral immune cells in both health and disease

Clinical features in antiglycine receptor antibody-related disease: a case report and update literature review